Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment
Clinical trial NCT04970043 · UNKNOWN
Trial details
- NCT number
- NCT04970043
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-31
- Primary completion
- 2024-07-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.